Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 24, 2020

View Archived Issues

Preclinical pilot study data presented for NX-P004 programme in IPF

Bristol-Myers Squibb identifies MGAT2 inhibitors for metabolic disorders

Tyrosine kinase controls AD tau aggregation in vivo

A novel thermally stable mRNA vaccine candidate protects mice against SARS-CoV-2 challenge

Islet organoids can evade immune attack

NSC-801845, a novel cytidine analogue with excellent activity in number of tumor models

First-in-human data presented for the live-attenuated RSV vaccine, RSVdeltaG

Janssen presents new anti-influenza nucleosides

New CDK2/cyclin E inhibitors discovered at Pfizer

Velexbru granted supplemental approval in Japan

Femtogenix discloses G-A crosslinking cytotoxic agents

New KDM1A inhibitors synthesized at Hanmi Science

Jiangsu Chia Tai Tianqing Pharmaceutical, Medshine Discovery patent PARP-1 inhibitors

FDA approves Xeomin for its first pediatric indication

Mechanisms of retinopathy come into focus

Targeting SARS-CoV-2 papain-like protease suppresses viral infection and promotes antiviral immunity

Opthea completes meeting with FDA and EMA for phase III clinical program of OPT-302 in wet AMD

First-in-class anticancer therapy ErSO targets estrogen receptor alpha-positive breast cancer

Roche begins phase II study of GDC-9545 for postmenopausal women with untreated early breast cancer

European Commission approves Kaftrio with ivacaftor for cystic fibrosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...